Amrize Ltd (AMRZ) AI Stock Analysis
AMRZ AI stock analysis summary
AI ResearchAmrize Ltd (AMRZ) is a North American building solutions provider with $12.18B in trailing twelve-month revenue. The company trades at a forward P/E of 13.4x, supported by an operating margin of 20.5% over the trailing twelve months. Its stock has declined 20.8% over the past year while the S&P 500 rose 16.8%.
- Market cap
- $20.68B
- Revenue (TTM)
- $12.18B
- P/E
- 17.3x fwd 13.4x
- 1Y return
- -20.8% S&P 500 16.8%
- Avg. target
- $47.20 24.8% vs last close
Bull case
- Quarterly earnings rose 14.7% year-over-year in the period ended June 30, 2026.
- Free cash flow generation remained solid at $1.42B in FY2025.
- The analyst mean price target of $47.20 offers 24.8% upside over the last closing price of $37.82.
Bear case
- The stock has dropped 29.2% year-to-date and sits 25.9% below its 200-day average.
- The company carries $5.90B in net debt, with total debt of $6.63B against cash of $729.0M.
- Amrize exceeded consensus EPS estimates in only 1 of the trailing 4 quarters.
What Amrize does
Amrize AG provides building solutions for infrastructure, commercial, and residential construction markets across North America and Canada. The company conducts business through two primary segments: Building Materials and Building Envelope. The Building Materials segment supplies cement, aggregates, ready-mix concrete, asphalt, and related construction materials. The Building Envelope segment manufactures advanced roofing and wall systems, including single-ply membranes, insulation, shingles, sheathing, waterproofing, protective coatings, adhesives, tapes, and sealants. Originally known as Holcim North America Finance Ltd, the company became Amrize AG in December 2013, was incorporated in 2023, and is headquartered in Zug, Switzerland.
Growth and profitability
Amrize generated revenue of $11.81B in FY2025, up from $8.13B in FY2021, reflecting a 4-year compound annual growth rate of 9.8%. Annual net income reached $1.19B in FY2025, corresponding to a 10.0% net margin and an operating margin of 16.1%. Over the trailing twelve months ended June 30, 2026, revenue totaled $12.18B with an operating margin of 20.5% and diluted earnings per share of $2.19. In the quarter ended June 30, 2026, quarterly revenue grew 8.6% year-over-year, while quarterly earnings expanded 14.7% year-over-year.
Balance sheet and cash flow
As of June 30, 2026, Amrize held $729.0M in cash and short-term investments against $6.63B in total debt, resulting in net debt of $5.90B. Shareholders' equity stood at $12.86B, giving a debt-to-equity ratio of 0.52 and a current ratio of 1.10. Total assets reached $24.60B at quarter-end. In FY2025, the company generated $2.21B in operating cash flow and $1.42B in free cash flow, deploying $788.0M toward capital expenditures.
Valuation and performance
Amrize trades at a trailing P/E of 17.3x, below the 19.7x median of its US-listed Basic Materials peers. Its forward P/E of 13.4x matches the peer median of 13.4x, while its EV-to-EBITDA multiple of 9.6x sits below the peer median of 10.5x. The company carries an enterprise value of $27.37B and a market cap of $20.68B. Over the past year, AMRZ shares fell 20.8%, trailing the S&P 500 benchmark return of 16.8%.
AMRZ dividend
Amrize carries an annual forward dividend of $0.44 per share, with a dividend yield listed at 0.00% and a payout ratio of 27.3%. Its last ex-dividend date occurred on August 18, 2026.
What analysts expect
Wall Street coverage includes 7 Strong Buy, 3 Buy, 8 Hold, 2 Sell, and 0 Strong Sell ratings. The mean price target is $47.20, representing 24.8% upside relative to the October 16, 2026 closing price of $37.82. For the fiscal year ending December 31, 2026, analysts estimate EPS of $2.42 on revenue of $12.51B. Amrize has beaten EPS estimates in 1 of the last 4 quarters, with its next earnings release scheduled for October 28, 2026.
Key risks and what to watch
- Total debt of $6.63B creates ongoing financing obligations relative to cash holdings of $729.0M.
- Full-year revenue growth slowed from 31.9% in FY2022 to 0.9% in FY2025.
- The company maintains a modest current ratio of 1.10 as of June 30, 2026.
AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer
About this AMRZ AI stock analysis
This page is an AI-written research summary of Amrize Ltd (AMRZ). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.
Related: AMRZ income statement, AMRZ balance sheet, AMRZ key metrics, AMRZ analyst forecast, AMRZ chart. See the AMRZ stock overview for the latest quote and news.
AMRZ AI stock analysis FAQ
What are analysts forecasting for Amrize in FY2026?
Analysts project full-year EPS of $2.42, representing 13.1% growth, on total revenue of $12.51B for the fiscal year ending December 31, 2026.
How much debt does Amrize have?
As of June 30, 2026, Amrize held $6.63B in total debt and $729.0M in cash and short-term investments, resulting in net debt of $5.90B and a debt-to-equity ratio of 0.52.
Does Amrize pay a dividend?
Amrize shows an annual forward dividend of $0.44 per share with a payout ratio of 27.3%, though its dividend yield is listed at 0.00%.
When is the next Amrize earnings report?
The company's next earnings report is scheduled for October 28, 2026.